Stock-Based Compensation
$55.97M
TTM · Period ending: · USD
PCRX Stock-Based Compensation
Latest reported$55.97Mperiod ending
Latest reported$55.97Mperiod ending
PCRX Stock-Based Comp ($242.00K → $55.97M)
Annual stock-based compensation
High-resolution chart · PNG
PCRX stock-based compensation history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 57,502,000 | |
| 51,171,000 | |
| 47,895,000 | |
| 48,092,000 | |
| 42,246,000 | |
| 39,920,000 | |
| 33,650,000 | |
| 31,725,000 | |
| 31,601,000 | |
| 31,248,000 | |
| 33,368,000 | |
| 24,822,000 | |
| 11,513,000 | |
| 4,776,000 | |
| 2,493,000 | |
| 23,000 | |
| 524,000 | |
| 242,000 |